Atlas Trials

Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients

Clinical trial NCT04517305 · COMPLETED

Trial details

NCT number
NCT04517305
Sponsor
Fudan University
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2018-05-15
Primary completion
2021-05-15
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.